BECOME OUR WEB ANGEL

Sponsor our new website and receive privileged access to our audience of business and academic leaders interested in corporate responsibility and sustainability.

Feature your brand and vision for a more sustainable future here.
Contact us now with your sponsorship offer.

subtitle shell

We help to meet the world’s growing energy needs in economically, environmentally and socially responsible ways. Our Business Principles have guided our choice of portfolio and products, and governed the way we operate for over 40 years.

subtitle ibm

The International Business Machines Corporation (commonly referred to as IBM) is an American multinational technology and consulting corporation, with headquarters in Armonk, New York, United States. IBM manufactures and markets computer hardware and software, and offers infrastructure, hosting and consulting services in areas ranging from mainframe computers to nanotechnology. 

subtitle

The International Business Machines Corporation (commonly referred to as IBM) is an American multinational technology and consulting corporation, with headquarters in Armonk, New York, United States. IBM manufactures and markets computer hardware and software, and offers infrastructure, hosting and consulting services in areas ranging from mainframe computers to nanotechnology. 

CORPORATE CITIZENSHIP TRUST

Johnson & Johnson is a company of enduring strength. We've been privileged to play a role in helping millions of people the world over be well and stay well through more than a century of change. As the science of human health and well-being has grown, we've been able to grow along with it. Even more important, we've helped shape and define what health and well-being means in every day lives. Our products, services, ideas and giving now touch the lives of at least one billion people everyday.

ESADE Business School, ABIS’ founding partner, is hosting the World Congress on “Spirituality and Creativity in Management: Challenges for the future” in Barcelona on 23 – 25 April 2015. Read more
23 Apr 2015
INDEG-IUL ISCTE Executive Education is offering a 4 days course in November 2014 and January 2015, in Lisbon. Portugal. This high level course will have international teachers like Edward Freeman (University of Virginia), Ivo Mulder (UNEP) or Arne van Oosterom (Partner at DesignThinkers Group). Read more
1 Nov 2014
The ‘Centre for Innovation and Change Leadership’ at Suffolk University is hosting the bi-annual symposium on Cross Sector Social Interactions (CSSI) on 29-30 May. Read more
29 May 2014
After a two-day workshop in 2005 with his top management team, Peter Walter, the founding CEO of betapharm, was wondering what he should do. betapharm, he knew, was a different kind of company: during the last 10 years, the generic-drug company had developed and been celebrated as a model corporate citizen and a socially responsible company. This recognition had positively reinforced betapharm’s culture and was a major source of inspiration for its employees. However, market conditions changed. Decision-making power started to shift from doctors and pharmacists towards institutions such as healthcare insurances, clinics and polyclinics with different requirements in procurement. At the same time market prices for generic drugs continued to erode. The changing circumstances caused cost and marketing challenges to arise as well as new business opportunities. The owner of betapharm, 3i, was calling for a clear strategy, which the workshop was designed to find. Walter was uncertain what that strategy should be: not only did he need to preserve the values that underlay the company’s culture and unique morale, but he had to do it in a profitable way both for the generic drug business and potential new business opportunities. While he discussed the threats and opportunities with his team, it became clear that more work had to be done to explore the several options. Read more
In this chapter, I shall argue how the onset of corporate responsibility (CR) holds a strong and powerful potential for improving motivation, commitment and identification among the workforce. In addition, I shall point at how CR may contribute in challenging and developing Organizational Behaviour (OB) in ways that will address the managerial complexity involved in unfolding CR strategies into corporate practice. Read more
On 17 January, 2000, the Boards of Glaxo Wellcome (Glaxo) and SmithKlineBeecham (SmithKline), two of Europe’s leading pharmaceutical companies, announced proposed terms of a merger; a deal that would create the second largest research-based pharmaceutical and healthcare company in the world, with a global workforce in excess of 100 000 and a combined market capitalization of £114 billion. Only US-based pharmaceutical giant Pfizer would be in a position to rival GlaxoSmith- Kline’s (GSK) £18.1 billion (US$27.5 billion) in global sales, R&D capabilities, extensive development pipeline and product range (see Exhibit 23.1 for an overview of GSK). Read more

No front page content has been created yet.